Hematology News

New guideline recommendations regarding the use of anticoagulants during heart surgery have been released by The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists and the American Society of ExtraCorporeal Technology.

New guideline recommendations regarding the use of anticoagulants during heart surgery have been released by The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists and the American Society of ExtraCorporeal Technology.

Results from a recent meta-analysis indicate that prolonged clopidogrel therapy in addition to aspirin has no effect on cancer or mortality rates.

Patients with monoclonal gammopathy of undetermined significance had a risk for progressing to multiple myeloma or another plasma-cell or lymphoid disorder, according to a 24-year study published in The New England Journal of Medicine.

The rate of arterial and venous thrombosis was significant in patients with myeloproliferative neoplasms, according to research published in Annals of Internal Medicine.

ATLANTA — A panel of customized induced pluripotent stem cells may allow for more efficient and safe matching of blood for transfusions among patients with sickle cell disease, according to a study presented during the plenary session of the ASH Annual Meeting and Exposition.

The FDA granted breakthrough therapy designation to voxelotor for the treatment of patients with sickle cell disease, according to a press release from the therapy’s manufacturer.

HemOnc Today honored its inaugural class of Next Gen Innovators during the ASH Annual Meeting and Exposition.

Female adolescents should undergo blood tests within a few years of menses to assess for iron deficiency, according to results of two cross-sectional studies.

The FDA granted breakthrough therapy designation to eltrombopag in combination with standard immunosuppressive therapy for the initial treat of severe aplastic anemia, according to the agent’s manufacturer.